Literature DB >> 17568368

Lyme disease--United States, 2003-2005.

.   

Abstract

Lyme disease is caused by the spirochete Borrelia burgdorferi and is transmitted to humans by the bite of infected blacklegged ticks (Ixodes spp.). Early manifestations of infection include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Left untreated, late manifestations involving the joints, heart, and nervous system can occur. A Healthy People 2010 objective (14-8) is to reduce the annual incidence of Lyme disease to 9.7 new cases per 100,000 population in 10 reference states where the disease is endemic (Connecticut, Delaware, Maryland, Massachusetts, Minnesota, New Jersey, New York, Pennsylvania, Rhode Island, and Wisconsin). This report summarizes surveillance data for 64,382 Lyme disease cases reported to CDC during 2003-2005, of which 59,770 cases (93%) were reported from the 10 reference states. The average annual rate in these 10 reference states for the 3-year period (29.2 cases per 100,000 population) was approximately three times the Healthy People 2010 target. Persons living in Lyme disease--endemic areas can take steps to reduce their risk for infection, including daily self-examination for ticks, selective use of acaricides and tick repellents, use of landscaping practices that reduce tick populations in yards and play areas, and avoidance of tick-infested areas.

Entities:  

Mesh:

Year:  2007        PMID: 17568368

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  42 in total

1.  Integrating spatial epidemiology into a decision model for evaluation of facial palsy in children.

Authors:  Andrew M Fine; John S Brownstein; Lise E Nigrovic; Amir A Kimia; Karen L Olson; Amy D Thompson; Kenneth D Mandl
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01

Review 2.  Lyme arthritis: current concepts and a change in paradigm.

Authors:  Dean T Nardelli; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

Review 3.  The emergence of Lyme disease in Canada.

Authors:  Nicholas H Ogden; L Robbin Lindsay; Muhammad Morshed; Paul N Sockett; Harvey Artsob
Journal:  CMAJ       Date:  2009-06-09       Impact factor: 8.262

4.  [Papilledema and thought disorder].

Authors:  S Waibel; L E Pillunat; E Matthé
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

5.  Evaluation of deer-targeted interventions on Lyme disease incidence in Connecticut.

Authors:  Jennifer M Garnett; Neeta P Connally; Kirby C Stafford; Matthew L Cartter
Journal:  Public Health Rep       Date:  2011 May-Jun       Impact factor: 2.792

Review 6.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

7.  Implications of gender in chronic Lyme disease.

Authors:  Gary P Wormser; Eugene D Shapiro
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

8.  A manganese transporter, BB0219 (BmtA), is required for virulence by the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  Zhiming Ouyang; Ming He; Tara Oman; X Frank Yang; Michael V Norgard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 9.  Burden of tick-borne infections on American companion animals.

Authors:  Zenda L Berrada; Sam R Telford
Journal:  Top Companion Anim Med       Date:  2009-11

10.  Interaction of Borrelia burgdorferi Hbb with the p66 promoter.

Authors:  Melisa S Medrano; Paul F Policastro; Tom G Schwan; Jenifer Coburn
Journal:  Nucleic Acids Res       Date:  2009-11-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.